Peer-reviewed articleOpen access

Intra-nasal esketamine induced psychotic disorder in a post COVID-19 major depressive episode: A case report.

Tang J, Munoz T, Jolivet I, Chappell K, Choucha W, Colle R, Verstuyft C, de Lepinau J, Corruble E, Gasnier M

L'EncephaleMay 10, 2023License: open accessFrance0 citationsDOI: 10.1016/j.encep.2023.05.001

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

KetamineDepression

Keywords

PsychosesNeuropsychiatryPsychosisMajor Depressive DisorderSuicidal IdeationSubstance-inducedIdées SuicidairesNeuropsychiatrieEsketamineCovid-19Induites Par Une SubstanceTroubles Dépressifs Majeurs

View paper Full text (PDF)

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.

Related research

ArticleKetamine

Pharmacologic Approaches to Suicide Prevention.

Zisook S, Domingues I, Compton J

Europe PMC2023

ArticleKetamine

Ketamine Assisted Psychotherapy: A Systematic Narrative Review of the Literature.

Drozdz SJ, Goel A, McGarr MW +6

Europe PMC2022

ArticleKetamine

Effects of ketamine on individual symptoms and symptom networks of depression in a randomised controlled trial of ketamine for treatment-resistant depression.

Hossein S, Rengasamy M, Uzamere A +5

Europe PMC2025